| Mr Larry M Mcbride, | |
|
800 Oak St, Farmville, VA 23901-1199 | |
| (434) 392-8811 | |
| (434) 315-2463 |
| Full Name | Mr Larry M Mcbride |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 26 Years |
| Location | 800 Oak St, Farmville, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326143389 | NPI | - | NPPES |
| 0024164502 | Other | VA | LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 0024164502 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Centra Southside Community Hospital, Inc | Farmville, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Centra Medical Group Llc | 4789606088 | 603 |
News Archive
Advanced Life Sciences Holdings, Inc., a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, today announced positive results from in vitro and in vivo studies assessing the efficacy of Restanza (cethromycin), its novel oral antibiotic, against the species of Plasmodium that cause malaria.
The Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) will establish eight Collaborative Research Centres (CRC) as of 1 January 2012. This was agreed by the responsible Grants Committee at its autumn meeting in Bonn.
Men over the age of 60 who have smoked at least 20 years are needed for an international clinical study to improve bladder cancer screening techniques at the University of Rochester Medical Center.
Drug discovery and development company Esperance Pharmaceuticals today announced that it has begun enrollment and dosing of patients in a Phase 1 study of EP-100 in patients with advanced solid tumors. EP-100, the lead candidate from Esperance's Cationic Lytic Peptide (CLYP(TM)) platform technology, is a targeted membrane-disrupting peptide (tMDP) designed to seek and destroy cancer cells that over-express luteinizing hormone releasing hormone (LHRH) receptors on their surfaces.
Four research teams at Columbia University will share a $2.1 million grant to mount an aggressive effort to identify potential antiviral drugs and antibodies for use against the new coronavirus, 2019-nCoV.
› Verified 6 days ago
| Entity Name | Centra Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649228966 PECOS PAC ID: 4789606088 Enrollment ID: O20051230000147 |
News Archive
Advanced Life Sciences Holdings, Inc., a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, today announced positive results from in vitro and in vivo studies assessing the efficacy of Restanza (cethromycin), its novel oral antibiotic, against the species of Plasmodium that cause malaria.
The Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) will establish eight Collaborative Research Centres (CRC) as of 1 January 2012. This was agreed by the responsible Grants Committee at its autumn meeting in Bonn.
Men over the age of 60 who have smoked at least 20 years are needed for an international clinical study to improve bladder cancer screening techniques at the University of Rochester Medical Center.
Drug discovery and development company Esperance Pharmaceuticals today announced that it has begun enrollment and dosing of patients in a Phase 1 study of EP-100 in patients with advanced solid tumors. EP-100, the lead candidate from Esperance's Cationic Lytic Peptide (CLYP(TM)) platform technology, is a targeted membrane-disrupting peptide (tMDP) designed to seek and destroy cancer cells that over-express luteinizing hormone releasing hormone (LHRH) receptors on their surfaces.
Four research teams at Columbia University will share a $2.1 million grant to mount an aggressive effort to identify potential antiviral drugs and antibodies for use against the new coronavirus, 2019-nCoV.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Larry M Mcbride, 800 Oak St, Farmville, VA 23901-1199 Ph: (434) 392-8811 | Mr Larry M Mcbride, 800 Oak St, Farmville, VA 23901-1199 Ph: (434) 392-8811 |
News Archive
Advanced Life Sciences Holdings, Inc., a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, today announced positive results from in vitro and in vivo studies assessing the efficacy of Restanza (cethromycin), its novel oral antibiotic, against the species of Plasmodium that cause malaria.
The Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) will establish eight Collaborative Research Centres (CRC) as of 1 January 2012. This was agreed by the responsible Grants Committee at its autumn meeting in Bonn.
Men over the age of 60 who have smoked at least 20 years are needed for an international clinical study to improve bladder cancer screening techniques at the University of Rochester Medical Center.
Drug discovery and development company Esperance Pharmaceuticals today announced that it has begun enrollment and dosing of patients in a Phase 1 study of EP-100 in patients with advanced solid tumors. EP-100, the lead candidate from Esperance's Cationic Lytic Peptide (CLYP(TM)) platform technology, is a targeted membrane-disrupting peptide (tMDP) designed to seek and destroy cancer cells that over-express luteinizing hormone releasing hormone (LHRH) receptors on their surfaces.
Four research teams at Columbia University will share a $2.1 million grant to mount an aggressive effort to identify potential antiviral drugs and antibodies for use against the new coronavirus, 2019-nCoV.
› Verified 6 days ago
Elizabeth C. Smith, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 800 Oak St, Farmville, VA 23901 Phone: 434-392-8811 Fax: 434-392-7654 | |
Melissa Kathryn Holmes, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 800 Oak St, Farmville, VA 23901 Phone: 804-517-0500 | |
Kristin Michelle Lakatos, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 800 Oak St, Farmville, VA 23901 Phone: 434-200-2300 | |
Susan Hammond, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 800 Oak St, Farmville, VA 23901 Phone: 434-315-2710 | |
Mr. Adelbert L Andrews, Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 800 Oak St, Farmville, VA 23901 Phone: 434-392-8811 Fax: 434-315-2463 | |
Mr. Frederick C Hill, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 800 Oak St, Atten: Julia Simon, Farmville, VA 23901 Phone: 434-315-2464 Fax: 434-315-2463 |